First Baby Discharged After Successful CRISPR Gene-Editing Treatment
TL;DR Summary
KJ Muldoon, the first patient to receive a personalized CRISPR gene editing therapy for severe CPS1 deficiency, was discharged after successful treatment, marking a significant milestone in rapid, customized treatment for rare genetic disorders and highlighting the potential for scalable, patient-specific gene therapies.
- First Personalized CRISPR Gene Editing Therapy Patient Baby KJ Discharged Inside Precision Medicine
- Pioneering gene editing therapy created by Eleanor Kaplan Foundation could give 5-year-old Pierce Hynes a new chance at life 6abc Philadelphia
- Baby saved by gene-editing therapy 'graduates' from hospital, goes home ABC News
- World's first patient treated with CRISPR gene editing therapy at CHOP returns home FOX 29 Philadelphia
- Baby KJ leaves CHOP after 307 days thanks to novel gene-editing therapy Inquirer.com
Reading Insights
Total Reads
0
Unique Readers
26
Time Saved
5 min
vs 6 min read
Condensed
96%
1,027 → 43 words
Want the full story? Read the original article
Read on Inside Precision Medicine